L-Carnitine treatment reduces severity of physical and mental fatigue and increases cognitive functions in centenarians: A randomized and controlled clinical trial

American Journal of Clinical Nutrition

Volumn 86, Issue 6, 2007, Pages 1738-1744

  Malaguarnera, Mariano ^a,b   Cammalleri, Lisa ^a   Gargante, Maria Pia ^a   Vacante, Marco ^a   Colonna, Valentina ^a   Motta, Massimo ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b CANNIZZARO HOSPITAL   (Italy)

Author keywords

Centenarians; Cognitive functions; Fatigue; L acetyl carnitine; L Carnitine

Indexed keywords

CARNITINE; CREATINE KINASE; CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LACTATE DEHYDROGENASE; LOW DENSITY LIPOPROTEIN; PLACEBO; TRIACYLGLYCEROL;

AGED; AGING; ARTICLE; CALORIC INTAKE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DEMOGRAPHY; DIETARY INTAKE; DISEASE COURSE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DYSTHYMIA; ELDERLY CARE; ENERGY METABOLISM; FATIGUE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MUSCLE MASS; NUTRITIONAL ASSESSMENT; OUTCOME ASSESSMENT; PHASE 2 CLINICAL TRIAL; PHYSICAL ACTIVITY; PHYSICAL CAPACITY; RANDOMIZED CONTROLLED TRIAL; UNSPECIFIED SIDE EFFECT;

EID: 36849090508     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/86.5.1738     Document Type: Article

References (36)

1. Malaguarnera M, Pistone G, Motta M. Mythology in medicine: the elderly and quality of life. Br Med J 1995;311:1136.
2. Motta M, Bennati E, Ferlito L, Malaguarnera M, Motta L. Italian Multicenter Study on Centenarians (IMUSCE). Successful aging in centenarians: myths and reality. Arch Gerontol Geriatr 2005;40:241-51.
3. Liu J, Head E, Kuratsune H, Cotman CW, Ames BN. Comparison of the effects of L-carnitine and acetyl-L-carnitine on carnitine levels, ambulatory activity, and oxidative stress biomarkers in the brain of old rats. Ann N Y Acad Sci 2004;1033:117-31.
4. Hagen TM, Ingersoll RT, Wehr CM, et al. Acetyl-L-carnitine fed to old rats partially restores mitochondrial function and ambulatory activity. Proc Natl Acad Sci U S A 1998;95:9562-6.
5. Wallace DC. Mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet 2005;39:359-407.
6. Brenner RR. Essential fatty acids: its transformations and functions Arch Latinoam Nutr 1983;33:735-47.
7. Long CS, Haller RG, Foster DW, McGarry JD. Kinetics of carnitine-dependent fatty acid oxidation: implications for human carnitine deficiency. Neurology 1982;32:663-6.
8. Pistone G, Marino A, Leotta C, Dell'arte S, Finocchiaro G, Malaguarnera M. Levocarnitine administration in elderly subjects with rapid muscle fatigue. Drugs Aging 2003;20:761-7.
9. Malaguarnera M, Pistone G, Receputo G et al. Serum carnitine levels in centenarians. Clin Drug Invest 1999;17:321-7.
10. Wessely S, Powell R. Fatigue syndromes: a comparison of chronic "postviral" fatigue with neuromuscular and affective disorders. J Neurol Neurosurg Psych 1989;52:940-8.
11. Krupp LB, La Rocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch. Neurol 1989;46:1121-3.
12. Folstein MF, Folstein SE, McHugh PR. "Mini Mental State" a practical method for grading the cognitive state of patients for the cognitive state of patients for the clinician. J Psychiatr Research 1975;12:189-98.
13. Maugeri D, Santangelo A, Abbate S, et al. Correlation between the bone mass, psychometric performances and the levels of autonomy and autosufficiency in an elderly Italian population above 80 years of age. Arch Gerontol Ger 2001;33:265271.
14. Malaguarnera M, Pistone G, Motta M, Lo Manto PC, Di Fazio I. Assessment of self-sufficiency in ultraoctogenarians. Arch Gerontol Geriatr 1996;22(suppl):505-8.
15. Hurst JW, Morris DC, Alexander RW. The use of the New York Heart Association's classification of cardiovascular disease as a part of the patient's complete problem list. Clin Cardiol 1999;22:385-90.
16. World Medical Association Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. JAMA 1997;277:925-6.
17. Cederblad G, Lindstedt S. A method for the determination of carnitine in the picomole range. Clin Chim Acta 1972;37:235-43.
18. Brass EP, Hoppel CL. Carnitine metabolism in the fasting rat. J Biol Chem 1978;253:2688-93.
19. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jafee MW. Studies of illness in the aged: the index of ADL: the standardized measure of biological and psychosocial function. JAMA 1963;185:914-9.
20. Hiatt WR, Regensteiner JG, Wolfel EE, Ruff L, Brass EP. Carnitine and acylcarnitine metabolism during exercise in humans. Dependence on skeletal muscle metabolic state. J Clin Invest 1989;84:1167-73.
21. Brass EP, Hoppel CL, Hiatt WR. Effect of intravenous L-carnitine on carnitine homeostasis and fuel metabolism during exercise in humans. Clin Pharmacol Ther 1994;55:681-92.
22. Brass EP. Overview of coenzyme A metabolism and its role in cellular toxicity. Chem Biol Interact 1994;90:203-14.
23. Brass EP, Hiatt WR. Carnitine metabolism during exercise. Life Sci 1994;54:1383-93.
24. Paradies G, Ruggiero FM, Petrosillo G, Gadaleta MN, Quagliariello E. Effect of aging and acetyl-L-carnitine on the activity of cytochrome oxidase and adenine nucleotide translocase in rat heart mitochondria. FEBS Lett 1994;350:213-5.
25. Paradies G, Petrosillo G, Gadaleta MN, Ruggiero FM. The effect of aging and acetyl-L-carnitine on the pyruvate transport and oxidation in rat heart mitochondria. FEBS Lett 1999;454:207-9.
26. Malaguarnera M, Di Mauro A, Gargante PM, Rampello L. L-carnitine reduces severity of physical and mental fatigue and improves daily activities in the elderly. South Med J 2006;99:315-6.
27. Siliprandi N, Di Lisa F, Menabo R, Ciman M, Sartorelli L. Transport and functions of carnitine in muscles. J Clin Chem Clin Biochem 1990;28:303-6.
28. Vecchiet L, Di Lisa F, Pieralisi G, et al. Influence of L-carnitine administration on maximal physical exercise. Eur J Appl Physiol Occup Physiol 1990;61:486-90.
29. Brevetti G, Angelini C, Rosa M, et al. Muscle carnitine deficiency in patients with severe peripheral vascular disease. Circulation 1991;84:1490-5.
30. Liu B, El Alaoui-Talibi Z, Clanachan AS, Schulz R, Lopaschuk GD. Uncoupling of contractile function from mitochondrial TCA cycle activity and MVO2 during reperfusion of ischemic hearts. Am J Physiol 1996;270:H72-80.
31. Montgomery SA, Thal LJ, Amrein R. Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease. Int Clin Psychopharmacol 2003;18:61-71.
32. Nalecz KA, Nalecz MJ. Carnitine-a known compound, a novel function in neural cells. Acta Neurobiol Exp (Wars) 1996;56:597-609.
33. Pettegrew JW, Levine J, McClure RJ. Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties: relevance for its mode of action in Alzheimer's disease and geriatric depression. Mol Psychiatry 2000;5:616-32.
34. Virmani A, Binienda Z. Role of carnitine esters in brain neuropathology. Mol Aspects Med 2004;25:533-49.
35. Rodrigues B, Xiang H, McNeill JH. Effect of L-carnitine treatment on lipid metabolism and cardiac performance in chronically diabetic rats. Diabetes 1988;37:1358-64.
36. Liu J, Head E, Gharib AM, et al. Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation partial reversal by feeding acetyl-L-carnitine and/or R-α-lipoic acid. Proc Natl Acad Sci U S A 2002;99:2356-61.